# Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer

> **NCT06777537** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Shandong University** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Talniflumate

## Key facts

- **NCT ID:** NCT06777537
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2030-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06777537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06777537, "Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06777537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*